arrow
T

Tatiana Sanz-Sánchez

hospital universitario san cecilio
H指数:11
被引数:447

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

湿疹病患者(急性与复发性水疱性皮炎)的流行病学、临床及过敏特征:西班牙接触性皮炎与皮肤过敏研究登记系统(REIDAC)的评估

2026-05-170
OAAI
Contact Sensitization in Patients With Frontal Fibrosing Alopecia: Patch Test Results With an Extended Baseline Series in Consecutive Patients

额部纤维变性脱发患者的接触性致敏:连续患者中使用扩展基线系列的斑贴试验结果

2026-04-060
OAAI
Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

与过敏性接触性皮炎当前相关性相关的临床因素:基于西班牙接触性皮炎登记处(REIDAC)数据开发的预测模型

2026-02-010
OAAI
Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024

肛门生殖器接触性皮炎在西班牙:REIDAC研究(2019-2024年进行斑贴试验的患者)

2025-12-010
OAAI
[[Translated article]]Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?

[[翻译后的文章]]羟基异己基3-环己烯羧醛(Lyral®)是否仍应包含在基础系列中?

2025-10-090
OAAI
The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain

儿童过敏性接触性皮炎的演变谱:一项在西班牙进行的多中心前瞻性研究

2025-08-180
PRE
¿Debe continuar el hidroxiisohexil 3-ciclohexeno carboxaldehído (Lyral®) en las baterías estándar de las pruebas epicutáneas?

是否应继续将羟异己基3-环己烯羧醛(Lyral®)纳入标准斑贴试验组合中?

2025-02-280
OAAI
Erythema, Localized Edema and Heat vs Forearm Perimeter Increase. Time to Revise the Consensus Recommendations on the Vortex Provocation Test in Vibratory Urticaria-Angioedema?
2025-02-010
OAAI
Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023
2024-10-120
OAAI
An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)
2024-08-200
OA
Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)
2024-08-130
PRE
A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight
2024-07-040
OA
Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)
2024-07-010
OAAI
Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

银屑病患者的流行病学、临床和过敏特征。西班牙接触性皮炎和皮肤过敏登记处 (REIDAC) 的评估

2024-06-010
OAAI
[Translated article] Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)
2024-06-010
OAAI
Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends
2024-04-010
OAAI
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis
2024-02-273
PRE
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
2024-02-133
OA